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Open access under CC BY-NIn their letter to the Editor, Christophe Combadière, William
Raoul, Xavier Guillonneau and Florian Sennlaub raise the following
concerns regarding our recent paper (Luhmann et al., Exp Eye Res.
2013; 107: 80):
They are concerned we imply that their Cx3cr1GFP/GFP or Cx3cr1/
mouse lines might carry the rd8 mutation. In our study, we did not
assert that the Cx3cr1GFP/GFP and Cx3cr1/ mouse lines studied by
Combadière et al. (J Clin Invest 2007; 117(10): 2920 or Chinnery et al.,
Neurobiol Aging2012; 33(8):1769) carry the rd8mutation, becausewe
know by personal communication that they do not. Nevertheless we
raised the general question, ‘whether the previously reported pheno-
type of different chemokine single knockout mice might also have
been affected by the rd8mutation.’, since there are other reports in the
literaturedescribing single chemokineknockoutmicewhere this isnot
clear. Because of the discrepancies in the phenotypes of lines with the
same chemokinedeﬁciency,wedecided to re-evaluate the age-related
retinal degeneration phenotype in our three newly established rd8-
free and related Ccl2/, Cx3cr1/ or Ccl2//Cx3cr1/mouse lines.
They also suggest that the comparison between our study and
others is not justiﬁed, since our animal lines were raised in
“signiﬁcantly dimmer light conditions than the light conditions
used in the previous publications”. However the lighting conditions
used in our studies were not signiﬁcantly dimmer than those
used in their study and are standard in most animal facilities.
We reported the illuminance of 38  28 lux (Mean  SD; range 7e
100 lux) measured during the 12 h light period inside the cages
when lids, food and water bottles were in place. This reﬂects the
average light levels the animals were directly exposed to during the
study period of 12e14 months. Just outside the cages, measured at.exer.2012.11.015.
ann).
C-ND license. the top, middle and bottom of the racks, we observed an illumi-
nance of 200  136 lux (range 50e500 lux). These are standard
lighting conditions in animal facilities and very similar to those
published in the papers we compared our observations to (Chin-
nery et al., Neurobiol Aging 2012; 33(8):1769: 230e275 lux source;
Combadière et al., J Clin Invest 2007; 117(10): 2920: 12-h/12-h dark
(range 100e500 lux)). Therefore a direct comparison seems valid.
Finally, they suggest that the only conclusion that could be
drawn safely from our data is “that none of the used mice strains
develop subretinal Mf/MCs accumulation or retinal degeneration
in very dim light conditions”. As explained above, we did not use
very dim, but standard light conditions. We speciﬁcally aimed to
determine the role of the chemokine genotypes (Ccl2/, Cx3cr1/
and Ccl2//Cx3cr1/) in the context of normal ageing under
standard housing conditions. Therefore our data supports the
conclusion that the chemokine deﬁciencies (Ccl2/, Cx3cr1/ and
Ccl2//Cx3cr1/) are not sufﬁcient on their own to cause age-
related retinal degeneration.
We have not tested whether additional exposure to higher light
levels (or any other additional exogenous trigger) might reveal any
altered susceptibility of the chemokine deﬁcient lines to degener-
ation. We discussed other factors that may contribute to the
phenotypic discrepancies observed, clearly stating that “such fac-
tors may include different ages, genetic backgrounds, or housing
conditions (light, pathogen load) or the presence of unknown
mutant alleles, similar to the homozygous Crb1 rd8 mutation,” The
main message of our paper is that at least one of these additional
factors is necessary for the manifestation of age-related retinal
degeneration in the context of chemokine deﬁciencies.
